Search Results 221-230 of 21401 for hepatitis
Stacey Rizza outlines the risk of being infected with hepatitis C, especially for people born between 1945 and 1965. Here's the Mayo Clinic Radio podcast ...
Acute cholangitis and alcohol-associated hepatitis. New Mayo Clinic research finds that machine-learning algorithms can help health care staff distinguish ...
Tenofovir alafenamide is used to treat chronic hepatitis B virus (HBV) infection in patients with compensated liver disease. This medicine is available only ...
Hepatitis caused by a virus — including hepatitis A, B and C — or caused by infectious mononucleosis. Nonalcoholic fatty liver disease (NAFLD), now known as ...
Viral hepatitis. Antiviral medicines are used to treat hepatitis B and hepatitis C. Effective treatment can lessen ongoing liver inflammation and lower the ...
A Study To Compare The Effectiveness And Safety Of ABT-493/ABT-530 To Sofosbuvir Given Together With Declatasvir In Adults With A Chronic Hepatitis C Virus ...
Unlike many cancers, the predisposing risk factors for most HCC cases are known, with chronic alcoholism, hepatitis B and C viral infection, and more ...
... hepatitis C infection. "The liver scarring from hepatitis C can take 20 to 30 years to develop into cancer," Dr. Kim says. "We're now seeing cancer patients ...
... hepatitis. He has written almost every clinical guideline on the treatment of autoimmune hepatitis and established that autoimmune hepatitis is a ...
A Study To Evaluate The Safety And Efficacy Of Ombitasvir/ABT-450/Ritonavir And Dasabuvir In Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.